SAPI Vision

To make innovative medicine accessible to patients in Singapore. We achieve this through a sustainable and valued partnership with healthcare professionals and providers, government and patient group stakeholders, and a reputation of consistent ethical behavior.

About SAPI

Our Association was founded on 26 May 1966. It was then known as the Pharmaceutical Trade Association.

On 19 December 1975, the Association’s name was changed to the Singapore Association of Pharmaceutical Industries (SAPI) so as to encompass a wider spectrum of pharmaceutical related businesses into the Association, namely the distributors, manufacturers, representative offices and affiliated companies.

In 2016, SAPI celebrated its 50th Anniversary; 50 years of contributing to the healthcare sector and community in many ways including enhancing quality of healthcare through innovative medicines and R&D, adding value to the economy through investment in biopharmaceutical manufacturing and clinical studies facilities and developing talents in the biopharmaceutical sector.

Our members are primarily research-based biopharmaceutical multinational companies with novel/ innovative products.

As a body, SAPI

  • Promotes ethical practices
    • High-standards of ethical practices
    • Self-regulating through our members’ voluntary acceptance and adherence to the SAPI Code of Conduct
  • Seeks collaborative dialogues

Promote the understanding of the value of innovative medicines, to extend and enhance human life, through effective dialogues with the government, healthcare professionals and other stakeholders.

SAPI Board of Directors

A Board of Directors comprising of 1 President, 2 Vice‑Presidents and 9 Directors, governs the Singapore Association of Pharmaceutical Industries. Board members are normally executive officers of member firms, who are elected by the association’s members at its general meetings.

The elected Board serves a two-year term from the date of its election.

Mr How Ti-Hwei

Mr. How Ti-Hwei
President

Country President
AstraZeneca Singapore Pte Ltd

ms-celine-ting

Ms Celine Ting
Vice-President

Managing Director
Eisai (Singapore) Pte Ltd

enver-erkan

Mr Enver Erkan
Vice-President

Country Manager
Pfizer Pte Ltd

Guillermo Frydman

Mr Guillermo Frydman
Director

Managing Director
Janssen Pharmaceutical

Ryan Harper

Mr Ryan Harper
Director

General Manager
Roche Singapore Pte Ltd

Tan Yan Ann

Ms Tan Yan Ann
Director

Chief Executive
Zuellig Pharma Pte Ltd

Ankur Pandey

Mr Ankur Pandey
Director

General Manager
DKSH Singapore Pte Ltd

Jennifer Yong

Ms Jennifer Yong
Director

General Manager- Pharma
Bayer (SEA) Pte Ltd

Robert Bowers

Mr Robert Bowers
Director

General Manager
GlaxoSmithKline Pte Ltd

Celine Landie

Ms Celine Landie
Director

Managing Director
Novartis (Singapore) Pte Ltd

Quek Wee Ling

Ms Quek Wee Ling
Director

Head of Sanofi Genzyme (Sin/Mal/Thai)
Sanofi-aventis Singapore Pte Ltd

Ashish Pal

Mr Ashish Pal
Director

Managing Director
MSD Pharma Pte Ltd

Membership

The Association’s membership structure comprises of Ordinary and Associate members.

Ordinary Member:

Any business entity involved directly in the marketing of pharmaceutical products in Singapore.  Generally, these companies are research-based multinational companies involved in Research and Development of novel products, and registered to operate in Singapore.

Associate Member:

Any business entity registered in Singapore, which is engaged in the promotion and advertising of medicinal products, or in the market research, publication or other activities related to medicinal products.

ORDINARY MEMBERS

ASSOCIATE MEMBERS

Tan Yan Ann

Finance & Development Committee

Ms Tan Yan Ann
Zuellig Pharma Pte Ltd

Celine Landie

Ethics & Business Integrity Committee

Ms Celine Landie
Novartis (Singapore) Pte Ltd

enver-erkan

Public Policy & Stakeholder Engagement Committee

Mr Enver Erkan
Pfizer Pte Ltd

Robert Bowers

Market Access Committee

Mr Robert Bowers
GlaxoSmithKline Pte Ltd

ms-celine-ting

Regulatory Affairs Committee

Ms Celine Ting
Eisai (Singapore) Pte Ltd

Ms Lily Lim
Senior Administration Officer

Ms Christina Teo
Executive Director

Ms May Wang
Accounts/Administration Officer

Contact: 6738 0966 (Telephone) 6738 0977 (Fax)

Email : admin@sapi.org.sg

APPLICATION FOR MEMBERSHIP WITH SAPI

Information on how to join SAPI membership:

We have TWO categories of membership:

  1. ORDINARY MEMBER:

This category is restricted to pharmaceutical companies involved directly in the marketing of pharmaceutical products in Singapore. Generally, these companies are research-based multinational companies involved in Research and Development of novel products, and registered to operate in Singapore

  1. ASSOCIATE MEMBER:

This category is open to any entity registered in Singapore, which is engaged in the promotion and advertising of medicinal products, or in the market research, publication or other activities related to medicinal products.

The application for membership shall be considered and approved by the SAPI Board of Directors. If approved, and upon payment of the prescribed entrance and membership fees, shall thereupon become a Member and shall enjoy all the privileges of the Association, except that Associate Members:

  • shall not Propose or Second any Member for election to the Board,
  • shall not vote at any General election
  • shall not be eligible to be a Board Director

Please email SAPI secretariat for more information and application forms at admin@sapi.org.sg

52nd Annual General Meeting (Members Only Event)

Call us to register at +65 6738 0966 or log in to register online.

Singapore Association of Pharmaceutical Industries

151 Chin Swee Road, #02-13A/14
Manhattan House, Singapore 169876
Tel : 6738 0966   Fax: 6738 0977